Cullinan Therapeutics Inc (CGEM)

08:10 AM

Cullinan Therapeutics (CGEM) Focuses on Key Clinical Programs - GuruFocus

08:10 AM

07:50 AM

Cullinan Therapeutics Inc Reports Q3 2025 EPS of -$0.77, Beating Estimates; Strong Cash Position at $475.5 Million - GuruFocus

07:50 AM

07:49 AM

Cullinan Therapeutics: Q3 Earnings Snapshot - San Francisco Chronicle

07:49 AM

07:47 AM

Cullinan Therapeutics' Q3 net loss widens - MarketScreener

07:47 AM

07:37 AM

Cullinan Management Reports Strong Q3 2025 Financial Results - TipRanks

07:37 AM

07:23 AM

Backtesting results for Cullinan Therapeutics Inc. trading strategiesJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com

07:23 AM

07:23 AM

Cullinan Therapeutics, Inc. SEC 10-Q Report - TradingView

07:23 AM

07:07 AM

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results - The Manila Times

07:07 AM

06:45 AM

Is Cullinan Therapeutics Inc. reversing from oversold territory2025 Market Trends & Expert Curated Trade Ideas - newser.com

06:45 AM

06:21 AM

Heatmap analysis for Cullinan Therapeutics Inc. and competitorsJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com

06:21 AM

06:15 AM

Can Cullinan Therapeutics Inc. stock attract ESG capital inflowsWall Street Watch & Expert Curated Trade Setups - newser.com

06:15 AM

05:54 AM

Cullinan Therapeutics Inc. stock trend forecast2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com

05:54 AM

03:30 AM

Using data filters to optimize entry into Cullinan Therapeutics Inc.Weekly Stock Report & Short-Term High Return Ideas - newser.com

03:30 AM

02:54 AM

What makes Cullinan Therapeutics Inc. stock attractive to growth fundsGold Moves & Daily Entry Point Alerts - newser.com

02:54 AM

Nov 05, 2025

Cullinan Therapeutics Inc. stock daily chart insightsTrade Exit Report & Safe Capital Growth Tips - newser.com

Nov 05, 2025

Nov 05, 2025

Will Cullinan Therapeutics Inc. stock maintain dividend yieldJuly 2025 EndofMonth & High Win Rate Trade Alerts - fcp.pa.gov.br

Nov 05, 2025

Nov 05, 2025

Why Cullinan Therapeutics Inc. stock remains undervaluedJuly 2025 Rallies & Expert Approved Momentum Ideas - fcp.pa.gov.br

Nov 05, 2025

Nov 05, 2025

Can Cullinan Therapeutics Inc. stock beat market expectations this quarterJuly 2025 Fed Impact & Growth Focused Entry Point Reports - newser.com

Nov 05, 2025

Nov 05, 2025

Cullinan Therapeutics Inc. stock outlook for YEARQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com

Nov 05, 2025

Nov 05, 2025

Is Cullinan Therapeutics Inc. trending in predictive chart modelsWeekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com

Nov 05, 2025

Nov 05, 2025

How Cullinan Therapeutics Inc. stock trades during market volatilityJuly 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com

Nov 05, 2025

Nov 05, 2025

Visual analytics tools that track Cullinan Therapeutics Inc. performanceJuly 2025 Rallies & Stepwise Trade Signal Implementation - newser.com

Nov 05, 2025

Nov 04, 2025

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Cullinan Management (CGEM) and Idexx Laboratories (IDXX) - The Globe and Mail

Nov 04, 2025

Nov 04, 2025

Is Cullinan Therapeutics Inc. stock a good choice for value investorsWeekly Market Report & High Accuracy Investment Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Will Cullinan Therapeutics Inc. stock recover after recent dropJuly 2025 Update & Daily Entry Point Alerts - newser.com

Nov 04, 2025

Nov 03, 2025

Cullinan Therapeutics (CGEM) Reveals Promising Phase 1 Data for CLN-049 in AML and MDS - GuruFocus

Nov 03, 2025

Nov 03, 2025

Cullinan Management Unveils Promising CLN-049 Clinical Data - TipRanks

Nov 03, 2025

Nov 03, 2025

Cullinan Therapeutics Presents New Data on CLN-049 at ASH Meeting - TradingView

Nov 03, 2025

Nov 03, 2025

Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting - GlobeNewswire

Nov 03, 2025

Nov 03, 2025

Cullinan (NASDAQ: CGEM) announces 69% ORR for CLN-049 in r/r AML; Phase 1 shows manageable safety - Stock Titan

Nov 03, 2025

Nov 03, 2025

What machine learning models say about Cullinan Therapeutics Inc.2025 Top Decliners & Reliable Price Breakout Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Cullinan Therapeutics Inc. rebound enough to break evenWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com

Nov 03, 2025